Employee Infections and Business Continuity Due to the Spread of COVID-19
First written in FY2020. 2 of 3 entries say "Mitigated", first in FY2021-Q1. Latest entry: FY2021.
The whole theme swung hardest in 2025: 2 of 12 companies on the "Worse" side.
3 other companies' latest entry also says "Mitigated".
- FY2021MitigatedAnnual report
「To prevent infections both inside and outside the Company and ensure the safety of employees working at locations throughout Japan, we have shifted mainly back-office employees to working from home. At Lab., our testing centers where large numbers of testers work, we have rigorously implemented infection prevention measures, including suspending attendance when employees have a fever, adjusting the number of employees coming to work by promoting staggered working hours, and distributing alcohol-based disinfectant and masks.」
The Company continued infection prevention measures, including working from home, suspending attendance when employees had a fever, staggered working hours, and distributing disinfectant and masks, making its response to the risk of business suspension due to employee infections more specific. - FY2021-Q1MitigatedAnnual report
「During the first quarter of the current fiscal year, we built a structure capable of providing services stably while thoroughly communicating infection prevention measures, including promoting remote work, suspending attendance when employees had a fever, and distributing alcohol-based disinfectant and masks.」
The Company implemented infection prevention measures, including remote work, suspending attendance when employees had a fever, and distributing disinfectant and masks, to address the risk of business suspension due to employee infections. - FY2020First statedAnnual report
「However, if employees become infected with COVID-19 and the infection spreads within the Company through contact among employees, this could affect our business operations, including through the temporary closure of Lab.」
The temporary closure of Lab. due to employee infections and its impact on business operations were newly disclosed as risks specific to COVID-19. Measures included working from home, infection prevention measures, decentralization of Lab. operations and remote debugging.